Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research interests include the genetics and epigenetics of NAS, breastfeeding in the setting of maternal substance use disorders, and the use of non-pharmacologic care methods to improve NAS outcomes. She is the neonatal lead of the Massachusetts (MA) neoQIC NAS Quality Improvement Collaborative. She was a site investigator in a NIDA funded clinical trial comparing the short-term and long-term outcomes of methadone versus morphine for NAS and is currently the principal investigator of a NICHD funded study examining the safety, efficacy, pharmacokinetics, pharmacogenomics, and long-term maternal and infant outcomes of extended-release naltrexone for pregnant women with opioid use disorder.
- Boston University School of Medicine, MD
- Georgetown University, BS
- Published on 3/1/2019
Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions. J Addict Med. 2019 Mar/Apr; 13(2):90-92. PMID: 30334926.
- Published on 1/25/2019
Wachman EM, Farrer LA. The genetics and epigenetics of Neonatal Abstinence Syndrome. Semin Fetal Neonatal Med. 2019 Jan 25. PMID: 30709700.
- Published on 1/22/2019
Wachman EM, Werler MM. Pharmacologic Treatment for Neonatal Abstinence Syndrome: Which Medication Is Best? JAMA Pediatr. 2019 Jan 22. PMID: 30667482.
- Published on 11/13/2018
Rose-Jacobs R, Trevino-Talbot M, Lloyd-Travaglini C, Cabral HJ, Vibbert M, Saia K, Wachman EM. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Addiction. 2019 Feb; 114(2):337-343. PMID: 30422365.
- Published on 11/6/2018
Howard MB, Wachman E, Levesque EM, Schiff DM, Kistin CJ, Parker MG. The Joys and Frustrations of Breastfeeding and Rooming-In Among Mothers With Opioid Use Disorder: A Qualitative Study. Hosp Pediatr. 2018 Nov 06. PMID: 30401783.
- Published on 9/1/2018
Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. Drug Alcohol Depend. 2018 11 01; 192:45-50. PMID: 30205307.
- Published on 8/28/2018
Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 12; 203:34-40.e1. PMID: 30170857.
- Published on 8/1/2018
Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, Lester B. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2018 Aug 01; 172(8):741-748. PMID: 29913015.
- Published on 5/8/2018
Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, Saia K, Nikita F, Khattab A, Nolin A, Alvarez C, Barry K, Combs G, Stickney D, Driscoll J, Humphreys R, Burke J, Farrell C, Shrestha H, Whalen BL. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018 Aug; 38(8):1114-1122. PMID: 29740196.
- Published on 4/19/2018
Wachman EM, Hayes MJ, Shrestha H, Nikita FNU, Nolin A, Hoyo L, Daigle K, Jones HE, Nielsen DA. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 2018 09; 17(7):e12476. PMID: 29575474.
View 19 more publications: View full profile at BUMC